Inflammation of the adipose tissue (Part 4). Obesity: a new infectious disease? (a literature review)
https://doi.org/10.14341/probl201157563-71
Abstract
References
1. Шварц В. Жировая ткань как эндокринный орган. Пробл эндокринол 2009; 55: 1: 38-44.
2. Flegal K.M., Carroll M.D., Ogden C.L., Johnson C.L. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002; 288: 14: 1723-1727.
3. World Health Organization. Obesity: preventing and managing a global epidemic: report of a WHO consultation on obesity. World Health Organ Tech Rep Ser 2000; 894: i-xii: 1-253.
4. Hedley A.A., Ogden C.L., Johnson C.L. et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004; 291: 23: 2847-2850.
5. Atkinson R.L. Could viruses contribute to the worldwide epidemic of obesity? Int J Pediat Obes 2008; 3: Suppl 1: 37-43.
6. Backhed F., Manchester J.K., Semenkovich C.F., Gordon J.I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 2007; 104: 979-984.
7. Lyons M.J., Faust I.M., Hemmes R.B. et al. A virally induced obesity syndrome in mice. Science 1982; 216: 4541: 82-85.
8. Griffond B., Verlaeten O., Belin M.F., Risold P.Y., Bernard A. Specific alteration of the expression of selected hypothalamic neuropeptides during acute and late mouse brain infection using a morbillivirus: relevance to the late-onset obesity? Brain Res 2004; 1022: 1-2: 173-181.
9. Dhurandhar N.V., Israel B.A., Kolesar J.M. et al. Increased adiposity in animals due to a human virus. Int J Obes Relat Metab Dis 2000; 24: 8: 989-996.
10. Pasarica M., Shin A.C., Yu M. et al. Human adenovirus 36 induces adiposity, increases insulin sensitivity, and alters hypothalamic monoamines in rats. Obesity (Silver Spring) 2006; 14: 11: 1905-1913.
11. So P.W., Herlihy A.H., Bell J.D. Adiposity induced by adenovirus 5 inoculation. Int J Obes (Lond.) 2005; 29: 6: 603-606.
12. Whigham L.D., Israel B.A., Atkinson R.L. Adipogenic potential of multiple human adenoviruses in vivo and in vitro in animals. Am J Physiol Regul Int Comp Physiol 2006; 290: 1: R190-R194.
13. Atkinson R.L., Dhurandhar N.V., Allison D.B. et al. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int J Obes (Lond.) 2005; 29: 3: 281-286.
14. Dhurandhar N.V., Israel B.A., Kolesar J.M. et al. Transmissibility of adenovirus-induced adiposity in a chicken model. Int J Obes Relat Metab Dis 2001; 25: 7: 990-996.
15. Pasarica M., Loiler S., Dhurandhar N.V. Acute effect of infection by adipogenic human adenovirus Ad36. Arch Virol 2008; 153: 2097-2102.
16. Vangipuram S.D., Yu M., Tian J. et al. Adipogenic human adenovirus-36 reduces leptin expression and secretion and increases glucose uptake by fat cells. Int J Obes (Lond.) 2007; 31: 1: 87-96.
17. Rathod M., Vangipuram S.D., Krishnan B. et al. Viral mRNA expression but not DNA replication is required for lipogenic effect of human adenovirus Ad-36 in preadipocytes. Int J Obes (Lond.) 2007; 31: 1: 78-86.
18. Rogers P.M., Fusinski K.A., Rathod M.A. et al. Human adenovirus Ad-36 induces adipogenesis via its E4 orf-1 gene. Int J Obes (Lond.) 2008; 32: 397-406.
19. Nabipour I., Vahdat K., Jafari S.M. et al. The association of metabolic syndrome and Сhlamydia pneumoniae, Helicobacter pylori, Cytomegalovirus, and herpes simplex virus type 1: The Persian Gulf Healthy Study. Cardiovasc Diabetol 2006; 5: 25-39.
20. Thjodleifsson B., Olafsson I., Gislason D. et al. Infections and obesity: A multinational epidemiological study. Scand J Inf 2008; 40: 381-386.
21. Lajunen T., Vikatmaa P., Bloigu A. et al. Chlamydial LPS and high-sensitivity CRP levels in serum are associated with an elevated body mass index in patients with cardiovascular disease. Inn Immun 2008; 14: 6: 375-382.
22. dos Santos V.M., da Cunha S.F., Teixeira V. de P. et al. Frequency of diabetes mellitus and hyperglycemia in chagasic and non-chagasic women. Rev Soc Bras Med Trop 1999; 32: 489-496.
23. Guariento M.E., Saad M.J., Muscelli E.O., Gontijo J.O. Heterogenous insulin response to an oral glucose load by patients with the indeterminate clinical form of Chagas' disease. Braz J Med Biol Res 1993; 26: 491-495.
24. Desruisseaux M.S., Nagajyothi R., Trujillo M.E. et al. Adipocyte, Adipose Tissue, and Infectious Disease. Infect Immun 2007; 75: 1066-1078.
25. Combs T.P., Nagajyothi, Mukherjee S. et al. The adipocyte as an important target cell for Trypanosoma cruzi infection. J Biol Chem 2005; 280: 24085-24094.
26. Batra A., Pietsch J., Fedke I. et al. Leptin-dependent Toll-like receptor expression and responsiveness in preadipocytes and adipocytes. Am J Pathol 2007; 170: 6: 1931-1941.
27. Ghanim H., Mohanty P., Deopurkar R. et al. Acute modulation of toll-like receptors by insulin. Diabet Care 2008; 31: 1827-1831.
28. Vitseva O.I., Tanriverdi K., Tchkonia T.T. et al. Inducible Toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue. Obesity (Silver Spring) 2008; 16: 5: 932-937.
29. Brikos C., O'Neill L.A. Signaling of toll-like receptors. Handb Exp Pharmacol 2008; 183: 21-50.
30. Suganami T., Tanimoto-Koyama K., Nishida J. et al. Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 2007; 27: 84-91.
31. Bès-Houtmann S., Roche R., Hoareau L. et al. Presence of functional TLR2 and TLR4 on human adipocytes. Histochem Cell Biol 2007; 127: 2: 131-137.
32. Chen J.X., Stinnett A. Critical role of the NADPH oxidase subunit p47phox on vascular TLR expression and neointimal lesion formation in high-fat diet-induced obesity. Lab Inv 2008; 88: 12: 1316-1328.
33. Nguyen M.T. et al. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by FFAS via TLR2, TLR4 and JNK-dependent pathways. J Biol Chem 2007; 282: 35279-35292.
34. Shi H., Kokoeva M.V., Inouye K. et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006; 116: 11: 3015-3025.
35. Creely S.J., McTernan P.G., Kusminski C.M. et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 2007; 292: 3: E740-E747.
36. Yu S., Cho H.H., Joo H.J. et al. Role of MyD88 in TLR agonist-induced functional alterations of human adipose tissue-derived mesenchymal stem cells. Mol Cell Biochem 2008; 317: 1-2: 143-150.
37. Tsukumo D.M., Carvalho-Filho M.A., Carvalheira J.B. et al. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007; 56: 8: 1986-1998.
38. Roncon-Albuquerque R., Moreira-Rodrigues M., Faria B. et al. Attenuation of the cardiovascular and metabolic complications of obesity in CD14 knockout mice. Life Sci 2008; 83: 13-14: 502-510.
39. Dela P.A., Leclercq I., Field J., George J., Jones B., Farrel G. NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis. Gastroenterology 2005; 129: 5: 1663-1674.
40. Cai Dongsheng, Yuan Minsheng, Frantz Daniel F. et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-Β and NF-χB. Nature Med 2006; 11: 2: 183-190.
41. Li Z., Yang S., Lin H., Huang J., Watkins P.A., Moser A.B. et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatol 2003; 37: 2: 343-350.
42. Kim F., Pham M., Luttrell I. et al. Toll like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circulat Res 2007; 100: 1589-1596.
43. Coenen K.R., Gruen M.L., Lee-Young R.S. et al. Impact of macrophage toll-like receptor 4 deficiency on macrophage infiltration into adipose tissue and the artery wall in mice. Diabetologia 2009; 52: 318-328.
44. Cani P.D., Amar J., Iglesias M.A. et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56: 1761-1772.
45. Erridge С., Attina T., Spickett C.M., Webb D.J. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 2007; 86: 1286-1292.
46. Wiedermann C.I., Kiechl S., Dunzendorfer S. et al. Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. J Am Coll Cardiol 1999; 34: 1975-1981.
47. Nolan J.P., Hare D.K., McDevitt J.J., Ali M.V. In vitro studies of intestinal endotoxin absorption. I. Kinetics of absorption in the isolated everted gut sac. Gastroenterology 1977; 72: 434-439.
48. Rao R.K., Seth A., Sheth P. Recent advances in alcoholic liver disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 2004; 286: 881-884.
49. Wolowczuk I., Verwaerde C., Viltart O. et al. Feeding Our Immune System: Impact on Metabolism. Clin Dev Immunol 2008; 2008: 639-803.
50. Neels J.G., Olefsky J.M., Desai M. et al. Inflamed Fat: what starts the fire? J Clin Invest 2006; 116: 33-35.
51. Lee J.Y., Hwang D.H. The modulation of inflammatory gene expression by lipids: mediation through Toll-like receptors. Mol Cells 2006; 21: 2: 174-185.
52. Schaeffler A., Gross P., Buettner R. et al. Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-kappaB pathway in adipocytes links nutritional signalling with innate immunity. Immunology 2009; 126: 233-245.
53. Davis J.E., Gabler N.K., Walker-Daniels J., Spurlock M.E. Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity (Silver Spring) 2008; 16: 6: 1248-1255.
54. Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001; 294: 5548: 1871-1875.
55. Pond C.M. Paracrine relationships between adipose and lymphoid tissues: implications for the mechanism of HIV-associated adipose redistribution syndrome. Tr Immun 2003; 24: 13-18.
56. Schаеffler A., Schоеlmerich J., Buechler C. Mechanisms of disease: adipocytokines and visceral adipose tissue-emerging role in intestinal and mesenteric diseases. Nature Clin Pract Gastroenterol Hepatol 2005; 2: 2: 103-111.
57. Magee T., Pirinen N., Adler J., Pagakis S.N., Parmryd I. Lipid rafts: cell surface platforms for T cell signaling. Biolog Res 2002; 35: 2: 127-131.
58. Mattacks C.A., Sadler D., Pond C.M. The effects of dietary lipids on dendritic cells in perinodal adipose tissue during chronic mild infammation. Br J Nutr 2004; 91: 883-892.
59. Ciofani M., Zuniga-Pflucker J.C. Notch promotes survival of pre-T cells at the b-selection checkpoint by regulating cellular metabolism. Nat Immunol 2005; 6: 881-888.
60. Maratou E., Dimitriadis G., Kollias A. et al. Glicose transporter expression on the plasma membrane of resting and activated white blood cells. Eur J Clin Inv 2007; 37: 282-290
Review
For citations:
Shvarts V.I. Inflammation of the adipose tissue (Part 4). Obesity: a new infectious disease? (a literature review). Problems of Endocrinology. 2011;57(5):63-71. https://doi.org/10.14341/probl201157563-71
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
